EBS vs. ^GSPC

In the year-to-date period, EBS achieves a -40.90% return, which is significantly lower than ^GSPC's -3.77% return. Over the past 10 years, EBS has underperformed ^GSPC with an annualized return of -14.49%, while ^GSPC has yielded a comparatively higher 10.45% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Emergent BioSolutions Inc. (EBS) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current EBS Sharpe Ratio is 0.24, which is lower than the ^GSPC Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of EBS and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

The maximum EBS drawdown since its inception was -98.89%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for EBS and ^GSPC. For additional features, visit the drawdowns tool.